We have revised our Privacy Policy and Terms of Use. Click on each to view.
  • Español
  • Join Now
Dr. Daniel Sherer

Dr. Daniel Sherer MD, FAAD


Credentials of Dr. Daniel Sherer MD, FAAD


  • Medical School - State University of New York, Downstate Medical Center
  • Icahn School of Medicine at Mount Sinai, Residency in Dermatology
  • Icahn School of Medicine at Mount Sinai, Fellowship in Dermatopharmacology

Languages Spoken

Board Certifications

  • American Board of Dermatology

Professional Memberships

  • American Academy of Dermatology

Awards and Publications

  • First Prize in the New York Academy of Medicine Resident's Research Competition
  • Grant from the National Institute of Health
  • Sherer DW, Singer G, Uribarri J, Phelps RG, Sapadin AN, Freund KB, Yanuaai L, Fuchs W, Lebwohl M. Oral Phosphate Binders In the Treatment of Pseudoxanthoma Elasticum. Journal of the American Academy of Dermatology. 2005; 53(4): 610-15.
  • Sherer D, Kong J, Waldorf H, Lebwohl M. Laser Therapy in the Treatment of Resistant Psoriatic Plaques. Journal of Aesthetic Dermatology and Cosmetic Dermatologic Surgery. 1999; 1(1): 43-8.
  • Sherer DW, Bercovitch L, Lebwohl M. Pseudoxanthoma elasticum: significance of limited phenotypic expression in parents of affected offspring. Journal of the American Academy of Dermatology. 2001;44(3):534-7.
  • Sherer DW, Lebwohl MG. 6-thioguanine in the treatment of psoriasis: a case report and literature review. J Cutan Med Surg. 2002;6(6):546-50.
  • Sherer DW. Sapadin AN. Lebwohl MG. Pseudoxanthoma Elasticum: An update. Dermatology 1999; 199:3-7.
  • Sherer D. Lebwohl M. Mycophenolate Mofetil for Psoriasis. Psoriasis Forum. 1998; 4(4): 6. 1998.
  • Sherer D, Lebwohl M. Pseudoxanthoma Elasticum in The NORD Guide to Rare Diseases, Lippincott, Williams & Wilkins, 2002 (in press).
  • Sherer DW, Lebwohl MG. Just What Is This Thing Called PXE? National Association for Pseudoxanthoma Elasticum (NAPE, Inc.) Newsletter 2000; 8(3): 1-5.
  • Lebwohl M, Sherer D, Washenik K, Krueger G, Menter A, Koo J, Feldman SR. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. International Journal of Dermatology 2002;41: 269-274.
  • Bershad S, Singer GK, Parente JE, Tan M, Sherer DW, Persaud AN, Lebwohl M. Successful Treatment of Acne Vulgaris Using a New Method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. Archives of Dermatology. 2002; 138: 481-489.
  • Persaud A, Shamuelova E, Sherer D, Lou W, Singer G, Cervera C, Lamba S, Lebwohl M. Imiquimod 5% cream is safe and effective in the treatment of actinic keratosis. J Invest Dermatol 117(2):890, 2001.
  • Lowe N, Feldman S, Sherer D, Weiss J, Lin Y, Foley V, Soto P. Clobetasol Propionate Lotion 0.05%- An efficacious and safe alternative to Clobetasol Propionate Emollient Cream, 0.05% offers a better remission profile to patients with plaque type psoriasis. Journal of Dermatological Treatment. 2005; 16(3): 158-64.

Professional Statement

Dr. Sherer is a Board Certified Dermatologist who has been in private practice on Long Island since 2003.

Dr. Sherer trained at the Mount Sinai School of Medicine where he completed his residency and Dermatopharmacology fellowship during which he participated in numerous clinical trials for new medications used to treat skin conditions such as psoriasis, acne, eczema, hair loss, hirsutism, photoaging, wrinkles, Ichthyosis Vulgaris, actinic keratoses, athlete's foot, wound healing, and laser treatments. Dr. Sherer remains on staff at Mount Sinai as an Assistant Clinical Professor where he teaches both dermatology residents and medical students.

Dr. Sherer received his undergraduate degree from Tufts University and attended medical school at SUNY Downstate Medical College. He is a Fellow of the American Academy of Dermatology and has published over a dozen original articles in professional journals. He was awarded First Prize in the New York Academy of Medicine Resident's Research Competition and a grant from the National Institute of Health for his research leading to a potential treatment of a connective tissue disease called Pseudoxanthoma Elasticum.

Dr. Sherer grew up in Syosset and enjoys giving back to the community in which he grew up by participating in local skin cancer screenings and lecturing at local schools and community centers. He is on staff at Mount Sinai Medical Center in Manhattan, North Shore/LIJ Huntington Hospital, North Shore/LIJ Plainview Hospital, North Shore/LIJ Syosset Hospital.

Patient Reviews for Dr. Daniel Sherer MD, FAAD

All reviews are from verified patients booked through ZocDoc

Book an Appointment

Choose your insurance
What's the reason for your visit?
Dermatology Consultation
Choose a time to book with Daniel Sherer, MD, FAAD
755 Park Avenue, Suite 500, Huntington, NY, 11743
400 South Oyster Bay Road,..., Hicksville, NY, 11801
Share Daniel Sherer, MD, FAAD with your network: